Related Experiment Video
Updated: May 16, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Safety of endoscopic sphincterotomy in patients under dual antiplatelet therapy
Insights
Endoscopic biliary sphincterotomy (ES) can be safely performed in patients undergoing dual antiplatelet therapy. This study found no bleeding events in patients on aspirin and clopidogrel who underwent this high-risk procedure.
Area of Science:
- Gastroenterology
- Cardiology
- Endoscopic Procedures
Background:
- Dual antiplatelet therapy (DAPT) is standard after coronary stent placement (bare metal stents: ≥1 month; drug-eluting stents: ≥1 year).
- Guidelines recommend delaying elective surgery until DAPT cessation due to bleeding risks.
- Limited data exist on bleeding risks for DAPT patients undergoing high-risk endoscopic procedures like biliary sphincterotomy.
Purpose of the Study:
- To evaluate the safety of performing endoscopic sphincterotomy (ES) in patients on dual antiplatelet therapy.
- To assess the bleeding risk associated with ES in patients receiving combined aspirin and clopidogrel therapy.
Main Methods:
- Retrospective analysis of medical records.
- Inclusion of patients who underwent endoscopic retrograde cholangiography with endoscopic sphincterotomy (ES) while on DAPT.
- Study period: January 2009 to December 2011.
Main Results:
- Eight consecutive patients on DAPT underwent ES.
- No instances of bleeding were observed in these patients post-procedure.
- ES was performed safely without complications related to antiplatelet therapy.
Conclusions:
- Endoscopic sphincterotomy (ES) appears to be a safe procedure for patients maintained on dual antiplatelet therapy.
- The findings suggest that DAPT does not necessarily preclude the performance of ES in urgent or necessary cases.
Background/Aims:
Dual antiplatelet therapy has to be used for at least one month after placement of bare metal coronary stents and for a minimum of one year after placement of drug eluting stents. Because of the higher risk of bleeding, guidelines strongly recommend to delay elective surgery until dual antiplatelet therapy is terminated. However, no data are available regarding the bleeding risk in patients on combined aspirin/clopidogrel therapy undergoing high-risk endoscopic procedures, such as emergency endoscopic biliary sphincterotomy.
Methodology:
We retrospectively analyzed the medical reports of patients who had to undergo endoscopic retrograde cholangiography with endoscopic sphincterotomy (ES) while on dual antiplatelet therapy in our unit between January 2009 and December 2011.
Results:
In our series, ES was safely performed in eight consecutive patients on dual antiplatelet therapy with no evidence of bleeding.
Conclusion:
ES may be safely performed in patients on dual antiplatelet therapy.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Aneurysm IV: Nursing Management
Endoscopic Procedures V: ERCP
Patient...